ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd (CU6)

2.28
-0.03
(-1.30%)
終了 6月7日 3:00PM

Clarity Pharmaceuticals Ltd (CU6) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
2.28
( -1.30% )
買値
2.25
売値
2.28
出来高
1,809,063
2.25 日の範囲 2.37
1.97 52 週間の範囲 5.87
時価総額
前日終値
2.31
始値
2.33
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
AUD 2,248,791
発行済株式数
372,258,073
配当利回り
PER
-8.85
1 株当たり利益 (EPS)
-0.28
歳入
10.58M
純利益
-96.35M

Clarity Pharmaceuticals Ltd について

Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate ... Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Sydney, Australia
設立
2026
Clarity Pharmaceuticals Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker CU6. The last closing price for Clarity Pharmaceuticals was AUD2.31. Over the last year, Clarity Pharmaceuticals shares have traded in a share price range of AUD 1.97 to AUD 5.87.

Clarity Pharmaceuticals currently has 372,258,073 shares in issue. The market capitalisation of Clarity Pharmaceuticals is AUD848.75 million. Clarity Pharmaceuticals has a price to earnings ratio (PE ratio) of -8.85.

CU6 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.29-11.28404669262.572.592.1827696992.38210672DE
4-0.65-22.18430034132.933.022.1821125122.62240316DE
12-1.67-42.27848101273.954.262.1823433762.99323504DE
26-0.94-29.19254658393.224.262.1822041543.17795935DE
520.2512.3152709362.035.871.9725971043.50653731DE
1561.54208.1081081080.748.9750.67516863653.79585625DE
2600.6338.18181818181.658.9750.3611491083.56496717DE

CU6 - Frequently Asked Questions (FAQ)

What is the current Clarity Pharmaceuticals Ltd share price?
The current share price of Clarity Pharmaceuticals Ltd is AUD 2.28
How many Clarity Pharmaceuticals Ltd shares are in issue?
Clarity Pharmaceuticals Ltd has 372,258,073 shares in issue
What is the market cap of Clarity Pharmaceuticals Ltd?
The market capitalisation of Clarity Pharmaceuticals Ltd is AUD 848.75M
What is the 1 year trading range for Clarity Pharmaceuticals Ltd share price?
Clarity Pharmaceuticals Ltd has traded in the range of AUD 1.97 to AUD 5.87 during the past year
What is the PE ratio of Clarity Pharmaceuticals Ltd?
The price to earnings ratio of Clarity Pharmaceuticals Ltd is -8.85
What is the cash to sales ratio of Clarity Pharmaceuticals Ltd?
The cash to sales ratio of Clarity Pharmaceuticals Ltd is 87.61
What is the registered address of Clarity Pharmaceuticals Ltd?
The registered address for Clarity Pharmaceuticals Ltd is National Innovation Centre, Sydney, New South Wales, 2015
What is the Clarity Pharmaceuticals Ltd website address?
The website address for Clarity Pharmaceuticals Ltd is www.claritypharmaceuticals.com
Which industry sector does Clarity Pharmaceuticals Ltd operate in?
Clarity Pharmaceuticals Ltd operates in the Biotechnology & Life Sciences sector

CU6 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock